Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Am J Prev Med. 2018 Nov;55(5):716-724. doi: 10.1016/j.amepre.2018.07.009.
The objective of this systematic review was to update a prior review and summarize the evidence on the impact of family planning reminder systems (e.g., daily text messages reminding oral contraception users to take a pill).
Multiple databases, including PubMed, were searched during 2016-2017 for articles published from March 1, 2011, to November 30, 2016, describing studies of reminder systems.
The search strategy identified 24,953 articles, of which two studies met the inclusion criteria. In total with the initial review, four studies (including two RCTs) examined reminder systems among oral contraception users, with two of three that examined correct use finding a statistically significant positive impact, and one RCT finding a positive impact on knowledge and continuation. Of three studies (including two RCTs) that examined reminder systems among depot medroxyprogesterone acetate users, one of three that examined correct use found a statistically significant positive impact on timely injections at 3 months, and one study found no effect on continued use at 12 months.
Although this review found mixed support for the effectiveness of reminder systems on family planning behaviors, the highest quality evidence yielded null findings related to correct use of oral contraception and timely depot medroxyprogesterone acetate injections beyond 3 months, and found positive findings related to oral contraception continuation and knowledge. Future studies would be strengthened by objectively measuring outcomes and examining additional contraceptive methods and outcomes at least 12 months post-intervention.
This article is part of a theme issue entitled Updating the Systematic Reviews Used to Develop the U.S. Recommendations for Providing Quality Family Planning Services, which is sponsored by the Office of Population Affairs, U.S. Department of Health and Human Services.
本系统评价的目的是更新先前的评价,并总结关于计划生育提醒系统(例如,每日提醒口服避孕药使用者服药的短信)对其产生影响的证据。
2016 年至 2017 年期间,通过多个数据库(包括 PubMed)检索了 2011 年 3 月 1 日至 2016 年 11 月 30 日期间发表的描述提醒系统研究的文章。
搜索策略确定了 24953 篇文章,其中有两项研究符合纳入标准。加上最初的综述,共有四项研究(包括两项 RCT)考察了口服避孕药使用者的提醒系统,其中三项研究中有两项发现正确使用的统计结果有显著的积极影响,一项 RCT 发现对知识和持续使用有积极影响。在三项研究(包括两项 RCT)中考察了 depot 醋酸甲羟孕酮使用者的提醒系统,其中三项研究中有一项发现及时注射 3 个月时有统计学上显著的积极影响,一项研究发现对 12 个月的持续使用没有影响。
尽管这项综述发现提醒系统对计划生育行为的有效性存在混合支持,但最高质量的证据表明,关于口服避孕药的正确使用和 depot 醋酸甲羟孕酮注射超过 3 个月的及时性的 RCT 结果为无效,而关于口服避孕药的持续使用和知识的 RCT 结果为阳性。未来的研究将通过客观地衡量结果和至少在干预后 12 个月检查其他避孕方法和结果来得到加强。
本文是题为“更新用于制定美国提供优质计划生育服务建议的系统评价”的主题问题的一部分,该主题问题由美国人口事务办公室赞助,美国卫生与公众服务部。